Nordmark Pharma is a Pharmaceutical company company operating in the pharmaceutical industry.
Nordmark produces Made in Germany biological active pharmaceutical ingredients and finished medicinal products from its own biological APIs, using a fully integrated approach for its own brands and for contract manufacturing purposes. Nordmark sells its products worldwide, mainly through other pharmaceutical partners. Nordmark’s API and Pharmaceutical Production processes adhere to national and international GMP-guidelines and are successfully agency inspected and certified by e.g. BfArM, FDA and ANVISA.
Company type
Pharmaceutical company
Products and services
Biopharmaceuticals, APIs (Active Pharmaceutical Ingredients)
Markets
Oceania, North America (USA, Canada), Africa, Middle East Region (e.g. UAE), Central America (e.g. Mexico), East Asia (e.g. China, Japan, Korea), Europe – EU countries, Europe – non EU (e.g. UK, Russia, ex-CIS countries), South America (e.g. Brazil, Colombia), South Asia (e.g. India, Pakistan, Sri Lanka), South East Asia (e.g. Thailand, Philippines, Singapore)
Useful Links
Connect with Nordmark Pharma on LinkedIn
Address
Nordmark Pharma, Pinnauallee 4, Uetersen, Germany, 25436
